Result Summary for 113572
| Protocol ID: | 113572 |
| Clinical Study ID: | 113572 |
| Official Title: | Immunogenicity and safety of GSK Biologicals’ pandemic influenza candidate vaccine GSK2340272A |
| Phase: | Phase 3 |
| Study Indications or Diseases: |
|
| Generic Name: | H1N1 Pandemic Influenza Vaccine |
| Trade/Product Name: | Pandemrix |
| Approved Drug Label: | http://www.gsk.com/products/prescription-medicines/index.htm |
| Results Summary: |
 Click here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
